Concord Medical Services (NYSE:CCM) Stock Crosses Above 200 Day Moving Average – Here’s Why

Concord Medical Services Holdings Limited (NYSE:CCM)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $4.23 and traded as high as $4.67. Concord Medical Services shares last traded at $4.39, with a volume of 19,609 shares traded.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Concord Medical Services Price Performance

The company has a debt-to-equity ratio of 1.33, a current ratio of 0.48 and a quick ratio of 0.46. The company has a 50-day moving average price of $4.71 and a two-hundred day moving average price of $4.23.

Concord Medical Services (NYSE:CCM) last announced its earnings results on Wednesday, April 29th. The company reported ($1.08) EPS for the quarter.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.